Separation of antithrombin III variants by micellar electrokinetic chromatography

被引:11
作者
Dönges, R
Römisch, J
Stauss, H
Brazel, D
机构
[1] Aventis Pharma, Qual Operat, D-35001 Marburg, Germany
[2] Aventis Behring, Res, D-35002 Marburg, Germany
关键词
sample injection; antithrombins; glycoprotein; proteins; enzyme inhibitors; heparin;
D O I
10.1016/S0021-9673(01)00827-5
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The characterisation of proteins is still one of the most challenging analytical tasks in modern bioanalysis. Due to the complex structure of proteins, several analytical techniques are often required to get sufficient information. Antithrombin III (AT III), a high-molecular-mass plasma glycoprotein which is an important protease inhibitor and the main modulator of thrombin activity, circulates in plasma in two isoforms, the so-called AT III-alpha (90-95%) and -beta (5-10%). Micellar electrokinetic chromatography was used to analytically separate these AT III variants, which differ in their affinity to the polysaccharide heparin. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:307 / 313
页数:7
相关论文
共 12 条
[1]  
BJORK I, 1992, BIOCHEM J, V286, P793
[2]   PHYSIOLOGICAL VARIANT OF ANTITHROMBIN-III LACKS CARBOHYDRATE SIDE-CHAIN AT ASN-135 [J].
BRENNAN, SO ;
GEORGE, PM ;
JORDAN, RE .
FEBS LETTERS, 1987, 219 (02) :431-436
[3]   High-performance capillary electrophoresis for in-process control in the production of antithrombin III and human clotting factor IX [J].
Buchacher, A ;
Schulz, P ;
Choromanski, J ;
Schwinn, H ;
Josic, D .
JOURNAL OF CHROMATOGRAPHY A, 1998, 802 (02) :355-366
[4]  
EVENSON MA, 1992, CLIN CHEM, V38, P1847
[5]   A STRATEGY FOR THE MAPPING OF N-GLYCANS BY HIGH-PERFORMANCE CAPILLARY ELECTROPHORESIS [J].
HERMENTIN, P ;
DOENGES, R ;
WITZEL, R ;
HOKKE, CH ;
VLIEGENTHART, JFG ;
KAMERLING, JP ;
CONRADT, HS ;
NIMTZ, M ;
BRAZEL, D .
ANALYTICAL BIOCHEMISTRY, 1994, 221 (01) :29-41
[6]   Determination of critical micelle concentration by capillary electrophoresis. Theoretical approach and validation [J].
Jacquier, JC ;
Desbene, PL .
JOURNAL OF CHROMATOGRAPHY A, 1995, 718 (01) :167-175
[7]   ANTITHROMBIN-III - STRUCTURAL AND FUNCTIONAL-ASPECTS [J].
MOUREY, L ;
SAMAMA, JP ;
DELARUE, M ;
CHOAY, J ;
LORMEAU, JC ;
PETITOU, M ;
MORAS, D .
BIOCHIMIE, 1990, 72 (08) :599-608
[8]   CHIRAL SEPARATION OF DILTIAZEM, TRIMETOQUINOL AND RELATED-COMPOUNDS BY MICELLAR ELECTROKINETIC CHROMATOGRAPHY WITH BILE-SALTS [J].
NISHI, H ;
FUKUYAMA, T ;
MATSUO, M ;
TERABE, S .
JOURNAL OF CHROMATOGRAPHY, 1990, 515 :233-243
[9]   DETERMINATION OF THE ENANTIOMER OF A CHOLESTEROL-LOWERING DRUG BY CYCLODEXTRIN-MODIFIED MICELLAR ELECTROKINETIC CHROMATOGRAPHY [J].
NOROSKI, JE ;
MAYO, DJ ;
MORAN, M .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1995, 13 (01) :45-52
[10]   CONTROL OF THE CULTIVATION PROCESS OF ANTITHROMBIN-III AND ITS CHARACTERIZATION BY CAPILLARY ELECTROPHORESIS [J].
REIF, OW ;
FREITAG, R .
JOURNAL OF CHROMATOGRAPHY A, 1994, 680 (02) :383-394